Core Insights - The podcast revisits a five-stock sampler from February 10, 2016, titled "Five Stocks to Feed the Bear," to evaluate performance over the past decade against the S&P 500, which returned 274.3% during that period [1][6][32] - The analysis includes lessons learned from the performance of these stocks, emphasizing the importance of long-term investing and the impact of market conditions on stock performance [3][34] Stock Performance Summary Stock 1: Carter's (Ticker: CRI) - Carter's stock price decreased from $85.04 to $38.07, resulting in a 55% decline, significantly underperforming the market [8][9] - The decline is attributed to a decreasing U.S. birth rate and challenges in the apparel retail sector, including increased costs due to tariffs and declining sales [8][9] Stock 2: IPG Photonics (Ticker: IPGP) - IPG Photonics' stock rose from $81.59 to $113.26, marking a 39% increase, but still lagging behind the market [12][13] - The company faced four consecutive years of declining revenue, which negatively impacted investor sentiment despite recent signs of recovery [12][13] Stock 3: Ellie Mae (Ticker: ELLI) - Ellie Mae was acquired for $99 per share in 2019, resulting in a 65% gain from the initial cost basis of $59.78, outperforming the market during its trading period [18][19] - The acquisition by Thoma Bravo and subsequent sale to Intercontinental Exchange highlighted the potential missed opportunities for early investors [19][20] Stock 4: Planet Fitness (Ticker: PLNT) - Planet Fitness' stock surged from $13.86 to $92.72, achieving a remarkable 569% increase, significantly outperforming the market [23][32] - The company demonstrated consistent revenue growth and resilience, even during the pandemic, which contributed to its strong performance [23][24] Stock 5: Mercado Libre - Mercado Libre's stock skyrocketed from $87.71 to $2,041.50, representing a staggering 2,227.6% increase, far exceeding the market return [26][32] - The company's growth was driven by its dominant position in the Latin American e-commerce market and the increasing shift of retail to online platforms [26][29] Overall Performance - The average return of the five stocks was 568.5%, significantly outperforming the S&P 500's 274.3% return over the same period [32] - The performance of Mercado Libre was pivotal in achieving this average, illustrating the power of a few high-performing stocks to drive overall portfolio success [31][32]

Core Insights - IPG Photonics shares surged 35.8% following impressive Q4 2025 earnings and strong Q1 guidance, despite broader market declines [1] - The stock remains 58% below its 2018 peak, reflecting challenges from industrial market weaknesses, competition, and geopolitical issues [2] Financial Performance - Q4 revenue increased by 17% to $274.5 million, with adjusted EPS rising 53% to $0.46, both exceeding estimates [4] - Management forecasts Q1 revenue between $235 million and $265 million and adjusted EPS of $0.10 to $0.40, surpassing analyst expectations [4] Market Recovery and Strategy - Industrial end markets appear to be stabilizing, with a new strategy focusing on high-profit and emerging markets beginning to yield results [3] - The battery production market in China is recovering, driven by a shift to advanced energy storage solutions requiring sophisticated welding techniques [7] Sector Growth - The medical end market grew by 21% in Q4, with new customers for urology lasers [8] - IPG is also benefiting from the semiconductor equipment segment, which is experiencing growth due to the AI revolution [8] New Product Development - IPG launched the CROSSBOW laser, a low-cost solution for the defense industry, aimed at neutralizing small drones [9] - A new facility in Alabama will be established to support the defense product line, marking an entry into a new market segment [9]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, with the aim of buying high and selling higher, capitalizing on established price movements [1] Company Overview: IPG Photonics (IPGP) - IPG Photonics currently holds a Momentum Style Score of B, indicating a favorable momentum characteristic [2] - The company has a Zacks Rank of 1 (Strong Buy), suggesting strong potential for outperformance in the market [3] Performance Metrics - Over the past week, IPG shares have increased by 18.61%, while the Zacks Lasers Systems and Components industry has remained flat [5] - In a longer timeframe, IPG shares have risen by 43.02% over the past month, significantly outperforming the industry's 4.17% [5] - For the last quarter, IPG shares have increased by 46.23%, and over the past year, they have risen by 76.12%, compared to the S&P 500's gains of 1.65% and 15.6%, respectively [6] Trading Volume - The average 20-day trading volume for IPG is 506,452 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, one earnings estimate for IPG has increased, raising the consensus estimate from $1.14 to $1.21 [9] - For the next fiscal year, two estimates have moved upwards with no downward revisions, indicating positive earnings momentum [9] Conclusion - Given the strong performance metrics and positive earnings outlook, IPG Photonics is positioned as a 1 (Strong Buy) stock with a Momentum Score of B, making it a compelling investment option [11]

Core Insights - Fourth quarter revenue increased by 17% year over year and 9% sequentially, driven by stabilization in industrial demand and growth in medical and advanced applications [1][20] - Medical sales grew by 21% in 2025, supported by new product introductions and FDA clearance for a next-generation urology system [7][47] - The company made significant progress in expanding its business beyond materials processing applications, with non-materials processing revenue accounting for approximately 14% of total revenue [6][11] Revenue Performance - Materials processing revenue rose by 17% year over year, with stable demand in general industrial applications and increased demand in battery and additive manufacturing [1][20] - Revenue from applications outside of materials processing increased by 15%, driven by higher sales in medical and advanced applications [20] - North America saw a 21% sequential and 23% year-over-year increase in sales, while Europe and Asia also reported growth [21][22] Financial Highlights - Total revenue for the fourth quarter was $274 million, with a GAAP gross margin of 36.1% and adjusted gross margin of 37.6% [20][23] - Operating income was $3 million, with adjusted EBITDA at $41 million, exceeding guidance [25] - The company ended the quarter with $839 million in cash and no debt, supporting ongoing capital allocation strategies [27][28] Strategic Initiatives - The company is focusing on growth in medical, micromachining, and advanced applications, with plans for new product introductions in 2026 [11][12] - The launch of the Crossbow laser defense system marks a significant step in directed energy applications, with strong customer interest reported [9][39] - The Clean Laser acquisition has contributed to revenue synergies and growth in cleaning applications, enhancing the company's competitive position [14][15] Market Outlook - Book-to-bill ratio remains above one, indicating strong order activity and improving market conditions [10][29] - Revenue guidance for Q1 2026 is projected between $235 million and $265 million, with expectations for adjusted gross margin between 37% and 39% [30] - The company remains cautiously optimistic about demand in 2026, while recognizing ongoing macroeconomic uncertainties [10][32]

Financial Data and Key Metrics Changes - Fourth quarter revenue increased by 17% year-over-year and 9% sequentially, driven by stabilization in industrial demand and growth in medical and advanced applications [5][10] - Full-year revenue grew by 3%, marking the first full-year revenue growth since 2021 [6] - GAAP gross margin was 36.1%, while adjusted gross margin was 37.6%, impacted by planned inventory management and tariffs [21][22] - GAAP net income was $13 million or $0.31 per diluted share, with adjusted net income at $20 million, resulting in earnings per diluted share of $0.46 [23] Business Line Data and Key Metrics Changes - Materials processing revenue increased by 17% year-over-year, with stable demand in welding and increased demand in battery and additive manufacturing applications [5][18] - Medical sales grew by 21% year-over-year, driven by new product traction and a major customer win [8][9] - Revenue from applications outside of materials processing increased by 15%, with significant growth in medical and advanced applications [18] Market Data and Key Metrics Changes - North America sales increased by 21% sequentially and 23% year-over-year, driven by higher revenue in cutting, cleaning, medical, and advanced applications [19] - Europe sales increased by 8% sequentially and 7% year-over-year, with strong growth in additive manufacturing and cleaning [19] - Asia revenue improved by 5% sequentially and 19% year-over-year, primarily due to higher welding sales in China [20] Company Strategy and Development Direction - The company is focusing on strengthening its position in core industrial applications while penetrating new non-industrial markets [12] - Growth initiatives in medical, micromachining, and defense are key investment priorities, with expectations for continued momentum into 2026 [11][12] - The company aims to expand its addressable market by integrating laser technology with applications expertise to address complex customer challenges [13] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding improving market conditions and customer demand, despite ongoing macroeconomic uncertainties [10][11] - Strong bookings in Q4 resulted in a book-to-bill ratio above one, indicating positive demand trends [10][26] - The company plans to maintain a balanced capital allocation strategy, investing in growth while returning capital to shareholders [25] Other Important Information - The company received FDA clearance for a next-generation urology system, enhancing its medical product offerings [9] - The cleanLASER acquisition has generated revenue synergies and contributed to growth in the cleaning segment [14][15] - The company has authorized a new $100 million share repurchase program to continue returning capital to shareholders [25] Q&A Session Summary Question: Thoughts on cutting revenue stability and long-term growth targets - Management noted that cutting revenue has stabilized and is expected to grow alongside investments in core markets [32][33] Question: Update on Directed Energy investment and market interest - Management reported strong customer interest in the Crossbow system for military and civilian applications, with plans for future product enhancements [37][38] Question: Margin improvement and revenue levels for fixed cost absorption - Management indicated that revenue levels above $270 million would help improve gross margins, with ongoing cost reduction initiatives in place [40][41] Question: Plans for investment in Directed Energy applications - Management confirmed a roadmap for increasing power levels in Directed Energy products, targeting smaller class drones [45] Question: Expectations for new medical products in 2026 - Management anticipates significant growth in medical sales, with new product launches planned for 2026 [46][47] Question: Competitive environment updates, especially in Asia - Management stated that pricing pressures are minimal in differentiated markets, with strong demand in battery and advanced applications [62] Question: Variability in bookings by region - Management reported broad-based order activity, with North America and Asia showing strong performance, while Europe is improving [68]

Financial Data and Key Metrics Changes - Fourth quarter revenue increased by 17% year-over-year and 9% sequentially, driven by stabilization in industrial demand and growth initiatives [5][18] - Full-year revenue grew by 3%, marking the first full-year revenue growth since 2021 [6] - GAAP gross margin was 36.1%, while adjusted gross margin was 37.6%, impacted by lower absorption of fixed costs and tariffs [21][22] - GAAP net income was $13 million or $0.31 per diluted share, with adjusted net income at $20 million, resulting in earnings per diluted share of $0.46 [23] Business Line Data and Key Metrics Changes - Materials processing revenue increased by 17% year-over-year, with stable demand in welding and growth in battery and additive manufacturing applications [5][18] - Medical sales grew by 21% year-over-year, driven by new product traction and a major customer win [8][9] - Revenue from applications outside materials processing increased by 15%, with strong growth in medical and advanced applications [18] Market Data and Key Metrics Changes - North America sales increased by 21% sequentially and 23% year-over-year, driven by higher revenue in cutting, cleaning, medical, and advanced applications [19] - Europe saw an 8% sequential increase and 7% year-over-year growth, primarily in additive manufacturing and cleaning [19] - Asia's revenue improved by 5% sequentially and 19% year-over-year, with strong demand in battery applications in China [20] Company Strategy and Development Direction - The company is focusing on expanding its business beyond materials processing, with 14% of total revenue coming from micromachining, medical, and advanced applications [8][11] - Strategic investments are being made in core industrial applications and new non-industrial markets, aiming to create new laser applications and expand the addressable market [12][13] - The company is evolving towards a team-led operating model to enhance decision-making and accelerate product development [11] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about improving market conditions and customer demand, despite ongoing macroeconomic uncertainties [10][28] - Strong bookings in Q4 resulted in a book-to-bill ratio above one, indicating positive demand trends [10][26] - The company anticipates revenue for Q1 2026 to be between $235 million and $265 million, with adjusted gross margin expected between 37% and 39% [26][27] Other Important Information - The company received a Prism Award for its new 8-kilowatt single-mode laser, reinforcing its position as a leader in fiber laser innovation [16] - The integration of cleanLASER has exceeded expectations, generating revenue synergies and enhancing growth in cleaning applications [14][15] Q&A Session Summary Question: Thoughts on cutting revenue stability and long-term growth targets - Management noted that cutting revenue has stabilized and is showing signs of growth, with ongoing investments in core markets [31][32] Question: Update on Directed Energy market and Crossbow product interest - Management reported strong customer interest in the Crossbow system, which targets military and civilian applications, and is seeing good traction in the market [35][38] Question: Margin improvement and revenue levels needed for fixed cost absorption - Management indicated that revenue levels above $270 million would help improve gross margins, with ongoing cost reduction initiatives in place [39][40] Question: Plans for investment in Directed Energy applications - Management confirmed a roadmap for increasing power levels in Directed Energy products, with plans for future product launches [45] Question: Expectations for new medical products in 2026 - Management expects significant growth in medical sales, with new product launches planned and a focus on doubling or tripling the business over the next few years [46][47] Question: Competitive environment and pricing pressures in Asia - Management stated that pricing pressures are minimal in differentiated markets, with strong demand in battery and advanced applications [60][61] Question: Variability in bookings by region - Management reported broad-based order activity, with North America and Asia performing well, while Europe showed signs of improvement [67]

Financial Data and Key Metrics Changes - Fourth quarter revenue increased by 17% year-over-year and 9% sequentially, driven by stabilization in industrial demand and growth in medical and advanced applications [5][17] - Full-year revenue grew by 3%, marking the first full-year revenue growth since 2021, with materials processing sales flat and welding revenue stable [6][9] - GAAP gross margin was 36.1%, while adjusted gross margin was 37.6%, impacted by planned inventory management and tariffs [20][22] Business Line Data and Key Metrics Changes - Materials processing revenue increased by 17% year-over-year, with strong performance in welding, marking, cleaning, and additive manufacturing [17] - Medical sales grew by 21% year-over-year, driven by new product traction and a major customer win [7][8] - Revenue from applications outside of materials processing accounted for approximately 14% of total revenue, with double-digit growth in micromachining, medical, and advanced applications [7][10] Market Data and Key Metrics Changes - North America sales increased by 21% sequentially and 23% year-over-year, driven by higher revenue in cutting, cleaning, medical, and advanced applications [18] - Europe saw an 8% sequential and 7% year-over-year increase, primarily from additive manufacturing and cleaning applications [18] - Asia revenue increased by 5% sequentially and 19% year-over-year, with strong demand in battery applications in China [19] Company Strategy and Development Direction - The company is focusing on strengthening its position in core industrial applications while penetrating new non-industrial markets, particularly in medical, micromachining, and directed energy [10][11] - The integration of cleanLASER has provided revenue synergies and enhanced growth in cleaning applications [12][13] - The company aims to capitalize on growth opportunities by combining laser technology with deep applications expertise to address complex customer challenges [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding improving market conditions and customer demand, despite ongoing macroeconomic uncertainties [9][10] - Strong bookings in Q4 resulted in a book-to-bill ratio above one, indicating positive demand trends [9][25] - The company plans to continue investing in growth initiatives while maintaining a strong balance sheet [24][26] Other Important Information - The company received a Prism Award for its new 8-kilowatt single-mode laser, reinforcing its position as a leader in fiber laser innovation [15] - The company is actively looking for tuck-in acquisitions to augment adjacent markets and accelerate growth [48][49] Q&A Session Summary Question: Thoughts on cutting revenue stability and long-term growth targets - Management noted that cutting revenue has stabilized and is expected to grow alongside investments in core markets like additive manufacturing and welding [31][33] Question: Update on Directed Energy opportunities and customer interest - Management reported strong customer interest in the Crossbow system for military and civilian applications, highlighting its differentiation and scalability [35][38] Question: Margin improvement and revenue levels needed for fixed cost absorption - Management indicated that revenue levels above $270 million could help improve gross margins, with ongoing cost reduction initiatives in place [39][40] Question: Plans for investment in Directed Energy applications - Management confirmed plans to increase investment in Directed Energy, with a roadmap for higher power systems in development [44][45] Question: Competitive environment and pricing pressures in Asia - Management stated that pricing remains stable in differentiated areas like battery and additive manufacturing, despite competitive pressures in cutting [60][61] Question: Updates on semiconductor exposure and growth expectations - Management highlighted engagement in lithography, metrology, and inspection, with expectations for growth aligned with semiconductor sector investments [71][72] Question: Clarification on micromachining and additive manufacturing applications - Management explained that additive manufacturing involves sintering powdered metal, while micromachining focuses on precision cutting and drilling for various industries [76][79]

分组1 - IPG Photonics reported quarterly earnings of $0.46 per share, exceeding the Zacks Consensus Estimate of $0.25 per share, and showing an increase from $0.18 per share a year ago, resulting in an earnings surprise of +82.54% [1] - The company achieved revenues of $274.47 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 11.40% and increasing from $234.34 million year-over-year [2] - IPG has consistently outperformed consensus EPS and revenue estimates over the last four quarters, indicating strong financial performance [2] 分组2 - The stock has gained approximately 54.9% since the beginning of the year, significantly outperforming the S&P 500's gain of 1.4% [3] - The current consensus EPS estimate for the upcoming quarter is $0.29 on revenues of $243.54 million, and for the current fiscal year, it is $1.55 on revenues of $1.04 billion [7] - The Lasers Systems and Components industry, to which IPG belongs, is currently ranked in the top 1% of over 250 Zacks industries, suggesting a favorable outlook for the sector [8]

Earnings Call Presentation Fourth Quarter 2025 February 12, 2026 10:00 am ET • By phone: 877-407-6184 in the US or 201-389-0877 internationally • A live webcast of the call will be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com Q4'25 Summary $274M Revenue $41M Adj. EBITDA $0.46 Adj. EPS © 2025 IPG PHOTONICS Note Regarding Forward Looking Statements and Use of Non-GAAP Financials Information and statements provided by IPG and its employees, incl ...

Financial Performance - Fourth quarter revenue reached $274.5 million, a 17% increase year-over-year, driven by growth in materials processing, medical, and advanced applications [5] - Gross margin for the fourth quarter was 36.1%, down from 38.6% in the previous year, impacted by higher product costs and tariffs [6] - Net income for the fourth quarter was $13.3 million, a 71% increase compared to $7.8 million in the same quarter last year [2] - Adjusted EBITDA for the fourth quarter was $41.2 million, an 11% increase from $37.3 million year-over-year [2] - Operating income for the fourth quarter was $3.3 million, a significant decrease of 76% from $14 million in the same quarter last year [2] - Net income for 2025 was $31,096,000, a significant recovery from a net loss of $181,526,000 in 2024 [20] - Adjusted gross profit for 2025 was $388,890,000, up from $370,039,000 in 2024, indicating a year-over-year increase of about 5% [32] - Adjusted gross margin improved to 38.7% in 2025 compared to 34.6% in 2024 [32] - Operating income for 2025 was $13,104,000, a recovery from an operating loss of $208,254,000 in 2024 [33] - Net income for Q4 2025 was $13,270,000, compared to $7,815,000 in Q4 2024, representing a 70.5% increase [34] - Adjusted EBITDA for Q4 2025 reached $41,230,000, up from $37,288,000 in Q4 2024, indicating a 5.2% growth [34] - Adjusted net income for the twelve months ended December 31, 2025, was $60,614,000, a decrease of 17.7% from $73,644,000 in 2024 [35] - Adjusted net earnings per diluted share for the twelve months ended December 31, 2025, was $1.42, down from $1.66 in 2024, reflecting a 14.5% decline [35] Future Projections - For Q1 2026, the company expects revenue between $235 million and $265 million, with adjusted gross margin projected between 37% and 39% [9] Investment and Growth - Emerging growth products accounted for 54% of total revenue, up from 52% in the prior quarter, indicating a positive trend in new product adoption [5] - The company plans to continue investing in innovation and new product roadmaps to support long-term growth [4] - The company made investments totaling $943,323,000 in 2025, compared to $713,151,000 in 2024, indicating a significant increase in investment activities [20] Shareholder Actions - The company authorized a new share repurchase program of up to $100 million, reflecting confidence in its financial position [7] Assets and Liabilities - Total assets increased to $2,424,280,000 in 2025 from $2,289,264,000 in 2024, representing a growth of approximately 5.9% [19] - Total current liabilities increased to $234,037,000 in 2025 from $205,019,000 in 2024, reflecting an increase of about 14.1% [19] - Cash and cash equivalents decreased to $403,790,000 at the end of 2025 from $620,040,000 at the end of 2024, a decline of approximately 34.9% [20] - Cash flows from operating activities for 2025 were $75,344,000, down from $247,896,000 in 2024 [20] Tax and Compensation - The company reported a non-GAAP tax provision of 16% for the fiscal fourth quarter of 2025 [31] - The effective tax rate for Q4 2025 was -26%, compared to 64% in Q4 2024, showing a significant change in tax impact [36] - The adjusted tax rate for Q4 2025 was 16%, a decrease from 46% in Q4 2024, reflecting a change in tax strategy [36] - Stock-based compensation for Q4 2025 was $10,180,000, an increase from $7,720,000 in Q4 2024, marking a 32.0% rise [34] - The company incurred acquisition and integration charges of $5,051,000 in Q4 2025, compared to $249,000 in Q4 2024, indicating a substantial increase in these costs [35] Demand Indicators - The book-to-bill ratio was above one, indicating strong demand and improved industrial activity, particularly in the U.S. and Asia [8]